Showing results (51-60 of 110) with videos related to
Sort By:
Pageof 11
Cancer Cell International|December 10, 2022
Lyve-1 deficiency enhances the hepatic immune microenvironment entailing altered susceptibility to melanoma liver metastasisAnna Sophia Jauch, Sebastian A Wohlfeil, Céline Weller, et al.Journal for Immunotherapy of Cancer|July 2, 2024
IFNγ mediates the resistance of tumor cells to distinct NK cell subsetsTomáš Hofman, Siu Wang Ng, Irene Garcés-Lázaro, et al.The Journal of Experimental Medicine|November 30, 2005
Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejectionJohn M Routes, Sharon Ryan, Kristin Morris, et al.Arthritis Research & Therapy|September 15, 2016
Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cellsWolfgang Merkt, Maren Claus, Norbert Blank, et al.International Journal of Cancer|May 18, 2010
NF-κ B-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interactionSonja Textor, Rosita Accardi, Tereza Havlova, et al.Oncoimmunology|October 21, 2016
Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell helpJing Ni, Oliver Hölsken, Matthias Miller, et al.Journal for Immunotherapy of Cancer|December 8, 2025
Colorectal cancer organoids drive hypoxia, TGF-β, and patient-specific diversification of NK cell activation programsAndreas von Kries, Irene Garcés-Lázaro, Bianca M Balzasch, et al.The Journal of Biological Chemistry|June 15, 2007
Identification of CLEC12B, an inhibitory receptor on myeloid cellsSabrina C Hoffmann, Carola Schellack, Sonja Textor, et al.The Journal of Clinical Investigation|November 11, 2014
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansionAlexander Rölle, Julia Pollmann, Eva-Maria Ewen, et al.Cytotherapy|April 18, 2015
Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapyMarkus Granzin, Stephanie Soltenborn, Sabine Müller, et al.Pageof 11